Death-seq identifies regulators of cell death and senolytic therapies.
Death-seq identifies regulators of cell death and senolytic therapies.
复制标题
Death-seq 识别细胞死亡和 senolytic 疗法的调节因子。
DOI:
10.1016/j.cmet.2023.08.008
复制
发表时间:
2023
期刊:
影响因子:
29
通讯作者:
Lai,
中科院分区:
文献类型:
--
作者:
Colville,Alex;Liu,Jie-Yu;Rodriguez-Mateo,Cristina;Thomas,Samantha;Ishak,HeatherD;Zhou,Ronghao;Klein,JulianDD;Morgens,DavidW;Goshayeshi,Armon;Salvi,JayeshS;Yao,David;Spees,Kaitlyn;Dixon,ScottJ;Liu,Chun;Rhee,June-Wha;Lai,
Selectively ablating damaged cells is an evolving therapeutic approach for age-related disease. Current methods for genome-wide screens to identify genes whose deletion might promote the death of damaged or senescent cells are generally underpowered because of the short timescales of cell death as well as the difficulty of scaling non-dividing cells. Here, we establish "Death-seq," a positive-selection CRISPR screen optimized to identify enhancers and mechanisms of cell death. Our screens identified synergistic enhancers of cell death induced by the known senolytic ABT-263. The screen also identified inducers of cell death and senescent cell clearance in models of age-related diseases by a related compound, ABT-199, which alone is not senolytic but exhibits less toxicity than ABT-263. Death-seq enables the systematic screening of cell death pathways to uncover molecular mechanisms of regulated cell death subroutines and identifies drug targets for the treatment of diverse pathological states such as senescence, cancer, and fibrosis.
登录
查看更多内容
影响因子:
5.6
作者:
N. Habuka;M. Miyano;J. Kataoka;M. Noma
通讯作者:
M. Noma
影响因子:
3.5
作者:
LEEHUANG, S;HUANG, PL;HUANG, PL
通讯作者:
HUANG, PL
DOI:
--
发表时间:
1990
期刊:
影响因子:
--
作者:
Y. Takanami;S. Kuwata;T. Ikeda;S. Kubo
通讯作者:
S. Kubo
影响因子:
6.1
作者:
N. Xuong;C. Nielsen;R. Hamlin;D. Anderson
通讯作者:
D. Anderson
影响因子:
4.8
作者:
N. Habuka;M. Miyano;J. Kataoka;H. Tsuge;M. Noma
通讯作者:
M. Noma